Description

n-[5-[(1Rs)-2-[Benzyl[(1Rs)-2-(4-Methoxyphenyl)- 1-Methylethyl]Amino]-1-Hydroxyethyl]-2- Hydroxyphenyl]Formamide is a sophisticated chiral organic compound with a complex molecular architecture, designed for advanced chemical synthesis. Its structure, featuring a formamide group and multiple chiral centers, makes it a valuable and highly specific building block in the development of novel active pharmaceutical ingredients (APIs) and fine chemicals. This compound is primarily targeted at pharmaceutical R&D and specialty chemical manufacturers engaged in the synthesis of complex molecules for therapeutic applications.

Application

• Pharmaceutical Intermediate: A key chiral precursor in the multi-step synthesis of potential drug candidates, particularly in central nervous system (CNS) and cardiovascular research.
• Asymmetric Synthesis Building Block: Utilized in the construction of complex molecules where its defined stereochemistry is critical for biological activity and process efficiency.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Fine Chemical Production: Employed in the manufacture of high-value, low-volume specialty chemicals requiring precise molecular control.
• Reference Standard: Used as an analytical standard for quality control and method development in pharmaceutical analysis.
• Catalyst and Ligand Development: Potential use in the design of novel chiral catalysts or ligands for enantioselective transformations.

Basic Information

Product Name	n-[5-[(1Rs)-2-[Benzyl[(1Rs)-2-(4-Methoxyphenyl)- 1-Methylethyl]Amino]-1-Hydroxyethyl]-2- Hydroxyphenyl]Formamide
CAS No.	2514947-17-0
Molecular Formula	C26H30N2O4
Molecular Weight	434.53 g/mol
Synonyms	Formamide, N-[5-[(1R)-2-[benzyl[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-1-hydroxyethyl]-2-hydroxyphenyl]-; (R)-N-(5-((R)-2-(Benzyl(2-(4-methoxyphenyl)propyl)amino)-1-hydroxyethyl)-2-hydroxyphenyl)formamide; Benzyl(1R)-2-(4-methoxyphenyl)-1-methylethyl]amine derivative; CAS 2514947-17-0; Advanced Chiral Amine Intermediate; Pharmaceutical Building Block 2514947-17-0
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Every batch is characterized using advanced analytical techniques including HPLC, NMR, and chiral analysis to confirm identity, purity, and enantiomeric excess. We adhere to a cGMP-compliant quality management system for pharmaceutical-grade material. Certificates of Analysis (COA) detailing all critical quality attributes are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% e.e.
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.